ArticleFrontiers in oncology2026

Long-term follow-up of tislelizumab combined with anlotinib in a single patient with metastatic type B3 thymoma: a case report.

Ting Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.